EyeCRO

EyeCRO is a leading brand specializing in preclinical ophthalmic contract research. With over two decades of experience in vision research, EyeCRO offers a wide range of services to examine the efficacy of novel test agents and therapeutic modalities. Their well-established and optimized models ensure reproducible data with meaningful endpoints.

EyeCRO's expertise extends to Toxicology/PK studies and the development of MiDROPS™, a revolutionary platform technology for ophthalmic drug delivery. MiDROPS™ allows for the formulation of lipophilic small molecules as eyedrops, utilizing thermodynamically stable microemulsions. These self-assembling vehicles enable high drug concentrations to be delivered to both the anterior and posterior segments of the eye.

EyeCRO holds broad patents covering millions of different formulations, protecting their innovative technology worldwide. The brand's capabilities also include A2E quantification, bioanalytical detection, biochemistry, histology, and ophthalmic imaging and physiology. EyeCRO's team of expert scientists works closely with clients to select the right model and experimental design to achieve their research and development goals.

With a commitment to excellence and innovation, EyeCRO is the go-to partner for preclinical ophthalmic research. Contact EyeCRO today to learn more about their specialized services and cutting-edge technology